Clinical Trial Update: Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial compares radiotherapy with single-agent cisplatin to combination chemotherapy for poor-prognostic cervical cancer; the trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Cervical Cancer | Phase 3 | Status: UNKNOWN